Release Date: 26/08/09 16:14 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 1.33MB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling